Acute fibrinous and organizing pneumonia associated with allogenic hematopoietic stem cell transplant successfully treated with corticosteroids: A two-patient case series

Lam Phuong Nguyen, Stella Ahdoot, Narin Sriratanaviriyakul, Yanhong Zhang, Nicholas Stollenwerk, Michael Schivo, Richart W Harper

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Acute fibrinous and organizing pneumonia (AFOP) is an extremely rare, relatively new, and distinct histological pattern of acute lung injury characterized predominately by the presence of intra-alveolar fibrin and associated organizing pneumonia. AFOP may be idiopathic or associated with a wide spectrum of clinical conditions. It has a variable clinical presentation from mild respiratory symptoms to that similar to the acute respiratory distress syndrome. Currently there is no consensus on treatment, and corticosteroids previously were of unclear benefit. To date, there are less than 40 cases of AFOP reported in the literature and only one has been linked to hematopoietic stem cell transplantation. Here we report the first case series of 2 patients who developed AFOP following allogenic stem cell transplant that were successfully treated with high-dose corticosteroids.

Original languageEnglish (US)
JournalJournal of Investigative Medicine High Impact Case Reports
Volume4
Issue number2
DOIs
StatePublished - Jan 1 2016

Fingerprint

Transplants
Hematopoietic Stem Cells
Stem cells
Pneumonia
Adrenal Cortex Hormones
Acute Lung Injury
Hematopoietic Stem Cell Transplantation
Adult Respiratory Distress Syndrome
Fibrin
Stem Cells
literature

Keywords

  • AFOP
  • Allogenic stem cell transplant
  • ARDS
  • BOOP
  • Diffuse alveolar damage

ASJC Scopus subject areas

  • Epidemiology
  • Safety, Risk, Reliability and Quality
  • Safety Research

Cite this

@article{66ecf6a1dbcc4696a8f44fd2efa8a532,
title = "Acute fibrinous and organizing pneumonia associated with allogenic hematopoietic stem cell transplant successfully treated with corticosteroids: A two-patient case series",
abstract = "Acute fibrinous and organizing pneumonia (AFOP) is an extremely rare, relatively new, and distinct histological pattern of acute lung injury characterized predominately by the presence of intra-alveolar fibrin and associated organizing pneumonia. AFOP may be idiopathic or associated with a wide spectrum of clinical conditions. It has a variable clinical presentation from mild respiratory symptoms to that similar to the acute respiratory distress syndrome. Currently there is no consensus on treatment, and corticosteroids previously were of unclear benefit. To date, there are less than 40 cases of AFOP reported in the literature and only one has been linked to hematopoietic stem cell transplantation. Here we report the first case series of 2 patients who developed AFOP following allogenic stem cell transplant that were successfully treated with high-dose corticosteroids.",
keywords = "AFOP, Allogenic stem cell transplant, ARDS, BOOP, Diffuse alveolar damage",
author = "Nguyen, {Lam Phuong} and Stella Ahdoot and Narin Sriratanaviriyakul and Yanhong Zhang and Nicholas Stollenwerk and Michael Schivo and Harper, {Richart W}",
year = "2016",
month = "1",
day = "1",
doi = "10.1177/2324709616643990",
language = "English (US)",
volume = "4",
journal = "Journal of Investigative Medicine High Impact Case Reports",
issn = "2324-7096",
publisher = "Sage Publications",
number = "2",

}

TY - JOUR

T1 - Acute fibrinous and organizing pneumonia associated with allogenic hematopoietic stem cell transplant successfully treated with corticosteroids

T2 - A two-patient case series

AU - Nguyen, Lam Phuong

AU - Ahdoot, Stella

AU - Sriratanaviriyakul, Narin

AU - Zhang, Yanhong

AU - Stollenwerk, Nicholas

AU - Schivo, Michael

AU - Harper, Richart W

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Acute fibrinous and organizing pneumonia (AFOP) is an extremely rare, relatively new, and distinct histological pattern of acute lung injury characterized predominately by the presence of intra-alveolar fibrin and associated organizing pneumonia. AFOP may be idiopathic or associated with a wide spectrum of clinical conditions. It has a variable clinical presentation from mild respiratory symptoms to that similar to the acute respiratory distress syndrome. Currently there is no consensus on treatment, and corticosteroids previously were of unclear benefit. To date, there are less than 40 cases of AFOP reported in the literature and only one has been linked to hematopoietic stem cell transplantation. Here we report the first case series of 2 patients who developed AFOP following allogenic stem cell transplant that were successfully treated with high-dose corticosteroids.

AB - Acute fibrinous and organizing pneumonia (AFOP) is an extremely rare, relatively new, and distinct histological pattern of acute lung injury characterized predominately by the presence of intra-alveolar fibrin and associated organizing pneumonia. AFOP may be idiopathic or associated with a wide spectrum of clinical conditions. It has a variable clinical presentation from mild respiratory symptoms to that similar to the acute respiratory distress syndrome. Currently there is no consensus on treatment, and corticosteroids previously were of unclear benefit. To date, there are less than 40 cases of AFOP reported in the literature and only one has been linked to hematopoietic stem cell transplantation. Here we report the first case series of 2 patients who developed AFOP following allogenic stem cell transplant that were successfully treated with high-dose corticosteroids.

KW - AFOP

KW - Allogenic stem cell transplant

KW - ARDS

KW - BOOP

KW - Diffuse alveolar damage

UR - http://www.scopus.com/inward/record.url?scp=85018227798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018227798&partnerID=8YFLogxK

U2 - 10.1177/2324709616643990

DO - 10.1177/2324709616643990

M3 - Article

AN - SCOPUS:85018227798

VL - 4

JO - Journal of Investigative Medicine High Impact Case Reports

JF - Journal of Investigative Medicine High Impact Case Reports

SN - 2324-7096

IS - 2

ER -